治疗艾滋病毒的长效注射里尔皮维林后的无菌
Nathan L'Etoile1,2, Elizabeth Lowenthal3,2
1Center for Clinical Epidemiology and Biostatistics , University of Pennsylvania , Philadelphia , Pennsylvania , USA.
BMJ case reports
|November 20, 2025
概括
对艾滋病毒的长效注射抗逆转录病毒疗法提供了更好的治疗满意度. 然而,在一个年轻的成年人中观察到一种罕见的无菌的副作用.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 长效注射抗逆转录病毒疗法 (LAI-ART) 代表了艾滋病毒管理的进步.
- 虽然一般耐受性很好,但轻微的注射部位反应是已知的不良事件.
- 与每日口服治疗方案相比,患者对LAI-ART的满意度显著提高.
研究的目的:
- 报告与LAI-ART相关的重大和不常见的不良事件.
- 要突出在注射性艾滋病药物的市场后监测期间观察到的特定副作用.
- 通知医疗保健提供者关于可能发生的严重注射部位反应.
主要方法:
- 病例报告详细说明特定患者的经验.
- 临床表现和诊断发现的描述.
- 在市场后药物监测期间对不良事件的审查.
主要成果:
- 一名年轻的成年患者在连续注射部位出现了无菌.
- 这些代表了与通常报告的轻度注射部位反应的显著偏差.
- 该事件发生在长效注射抗逆转录病毒疗法在市场上市后阶段.
结论:
- 无菌是一种潜在的,尽管很少见的,长效注射抗逆转录病毒治疗艾滋病毒的并发症.
- 对于注射部位显著反应的警在新艾滋病毒治疗模式的市场后监测期间至关重要.
- 这一案例强调了监测不常见的不良事件的重要性,即使一般安全和有效的疗法.
更多相关视频
04:29Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
Published on: November 1, 2024
820
09:54Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
10.5K
相关概念视频
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
239
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
239
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
224
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
224
